Old Web
English
Sign In
Acemap
>
Paper
>
Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience.
Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience.
2021
Antonella Bruzzese
Giovanni Manfredi Assanto
Daniela Diverio
Luisa Quattrocchi
D. Carmini
Ursula Larocca
Maria Stefania De Propris
Silvia Maria Trisolini
Mattia Brescini
Giulia Galassi
Walter Barberi
Anna Paola Iori
Keywords:
Single Center
Internal medicine
Oncology
Sorafenib
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
13
References
0
Citations
NaN
KQI
[]